Axium Capital Recommends Voting Against Soken Chemical's Director Nominees
大股東 Axium Capital 因綜研化學拒絕進行個別面談，宣布將對該公司董事及監事任命案投下反對票。
📋 Article Processing Timeline
- 📰 Published: May 16, 2026 at 00:04
- 🔍 Collected: May 15, 2026 at 15:32
- 🤖 AI Analyzed: May 15, 2026 at 18:57 (3h 24m after Collected)
Axium Capital, holding a 16% voting stake in Soken Chemical, announced its intention to vote against the re-election of several directors and statutory auditors. This decision comes after Soken Chemical repeatedly refused Axium's requests for individual meetings with the board members. Axium argues that this refusal violates corporate governance codes regarding constructive shareholder dialogue and raises concerns about the board's independence.